Actively Recruiting
Assessment System of Sarcopenia in Lung Cancer Patients
Led by West China Hospital · Updated on 2024-03-25
1500
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.
CONDITIONS
Official Title
Assessment System of Sarcopenia in Lung Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized patients scheduled for radical resection of lung cancer.
- Have had a CT or MRI examination within 1 week.
- Able to comply with the examination requirements.
You will not qualify if you...
- Amputated arm or leg.
- Severe edema above the knee.
- Presence of an implantable pacemaker.
- Impaired consciousness, poor general health, or inability to complete the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xinyi Tang
Chengdu, Sichuan, China
Actively Recruiting
Research Team
X
Xinyi Tang, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here